The DDL Conference is one of the largest annual conferences covering all aspects
of respiratory drug delivery.
DDL attracts a wide variety of attendees, including scientists, academics, clinicians, regulators and industry experts.
DDL offers the opportunity for lectures, posters and exhibitions to be closely located thereby enhancing interactions and networking opportunities for attendees, presenters and exhibitors.
DDL is a not-for-profit conference and any surplus funds are provided as grants or awards, targeted into research and training of the next generation of aerosol and drug delivery scientists.
DDL2021 will be the 32nd Drug Delivery to the Lungs Conference.